Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma-Reference-Cited by-同舟云学术

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

Published:2015-07-02 Issue:1 Volume:373 Page:23-34
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Larkin James¹,Chiarion-Sileni Vanna¹,Gonzalez Rene¹,Grob Jean Jacques¹,Cowey C. Lance¹,Lao Christopher D.¹,Schadendorf Dirk¹,Dummer Reinhard¹,Smylie Michael¹,Rutkowski Piotr¹,Ferrucci Pier F.¹,Hill Andrew¹,Wagstaff John¹,Carlino Matteo S.¹,Haanen John B.¹,Maio Michele¹,Marquez-Rodas Ivan¹,McArthur Grant A.¹,Ascierto Paolo A.¹,Long Georgina V.¹,Callahan Margaret K.¹,Postow Michael A.¹,Grossmann Kenneth¹,Sznol Mario¹,Dreno Brigitte¹,Bastholt Lars¹,Yang Arvin¹,Rollin Linda M.¹,Horak Christine¹,Hodi F. Stephen¹,Wolchok Jedd D.¹

Affiliation:

1. From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) — both in the United Kingdom; Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) — all in Italy; Division of Medical Oncology, University...

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1504030

Cited by 5767 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. References;The Evolution of Immunotherapy Against Tumors;2025

2. Mechanisms of resistance to immunotherapy;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

3. NK cell-based immunotherapy in hepatocellular carcinoma: An attractive therapeutic option for the next decade;Cellular Signalling;2024-12

4. A study on the efficacy and Safety Evaluation of a novel PD-1/CTLA-4 bispecific antibody;Immunobiology;2024-11

5. Advances in Vaccines for Melanoma;Hematology/Oncology Clinics of North America;2024-10